| CAMURUS AB |
| Schweden |
| Gesundheit |
| SE0007692850 / A2ABG7 |
| 7CA (Frankfurt) |
| FRA:7CA, ETR:7CA, 7CA:GR |
| - |
| https://www.camurus.com/ |
|
Camurus AB (publ) is a Swedish science-led biopharmaceutical company founded in 1991 and headquartered in Lund, specializing in the research, development, and commercialization of innovative, long-acting medicines for severe and chronic diseases. The..
>Volltext.. |
| 3350.49 Mio. EUR |
| 2994.12 Mio. EUR |
| 204.78 Mio. EUR |
| 78.08 Mio. EUR |
| 61.27 Mio. EUR |
| 1.03 EUR |
| 9.79 Mio. EUR |
| 367.57 Mio. EUR |
| 73.41 Mio. EUR |
| 8.26 |
| 0.7% |
| -4.94% |
| - |
| - |
| - |
| - |
| CAMURUS |
| 26.07.26 |
|
||||
|
||||
|
||||
|
||||
|